Inventor
FENAUX MARTIJN
US18 patents
⚠️ This page may combine multiple inventors who share the name “FENAUX MARTIJN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TERNS PHARMACEUTICALS INC
7 patentsUS12024507B2Jul 2, 2024
Compounds as GLP-1R agonists
TERNS PHARMACEUTICALS INC14 citations84
US12378236B2Aug 5, 2025
Compounds as GLP-1R agonists
TERNS PHARMACEUTICALS INC1 citations73
US12378238B2Aug 5, 2025
Compounds as GLP-1R agonists
TERNS PHARMACEUTICALS INC1 citations73
US12378237B2Aug 5, 2025
Compounds as GLP-1R agonists
TERNS PHARMACEUTICALS INC1 citations73
US12378239B2Aug 5, 2025
Compounds as GLP-1R agonists
TERNS PHARMACEUTICALS INC1 citations73
US12522596B2Jan 13, 2026
Compounds as GLP-1R agonists
TERNS PHARMACEUTICALS INC0 citations61
US12486261B2Dec 2, 2025
Compounds as GLP-1R agonists
TERNS PHARMACEUTICALS INC0 citations61
NOVARTIS AG
3 patentsUS9814739B2Nov 14, 2017
2′-ethynyl nucleoside derivatives for treatment of viral infections
NOVARTIS AG2 citations71
US10428105B2Oct 1, 2019
Alkynyl nucleoside analogs as inhibitors of human rhinovirus
NOVARTIS AG1 citations61
US9988416B2Jun 5, 2018
Alkynyl nucleoside analogs as inhibitors of human rhinovirus
NOVARTIS AG1 citations51